Answers are grounded in this paper and cite their sources.
Observational analysis associates low troponin I changes with 30-day mortality and MACE in patients with acute coronary syndrome.
In this study, we aimed to investigate the effect of variations in cardiac troponin I (cTnI) (delta troponin) levels-within the normal reference range-on 30-day mortality and non-fatal major adverse cardiac events (MACE) in patients who were monitored in the emergency department with a preliminary diagnosis of acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Torun et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: